Instil Bio Inc (TIL)
27.85
-0.93
(-3.23%)
USD |
NASDAQ |
Nov 04, 16:00
27.85
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Net Income (Quarterly): -14.92M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.92M |
| March 31, 2024 | -24.30M |
| December 31, 2023 | -12.92M |
| September 30, 2023 | -67.43M |
| June 30, 2023 | -18.66M |
| March 31, 2023 | -57.07M |
| December 31, 2022 | -53.84M |
| September 30, 2022 | -56.22M |
| June 30, 2022 | -58.99M |
| Date | Value |
|---|---|
| March 31, 2022 | -54.12M |
| December 31, 2021 | -55.35M |
| September 30, 2021 | -43.00M |
| June 30, 2021 | -35.31M |
| March 31, 2021 | -23.13M |
| December 31, 2020 | -17.18M |
| September 30, 2020 | -7.262M |
| June 30, 2020 | -9.202M |
| March 31, 2020 | -4.089M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-67.43M
Minimum
Sep 2023
-4.089M
Maximum
Mar 2020
-34.06M
Average
-29.81M
Median
Net Income (Quarterly) Benchmarks
| Merck & Co Inc | 3.157B |
| Elite Pharmaceuticals Inc | 0.6158M |
| BioCardia Inc | -1.646M |
| Zevra Therapeutics Inc | -19.92M |
| PetIQ Inc | 15.32M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 13.63M |
| EPS Diluted (Quarterly) | -2.29 |
| Enterprise Value | 120.50M |
| Earnings Yield | -66.18% |